Literature DB >> 3563961

Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever.

A Szczeklik, P C Milner, J Birch, J Watkins, J F Martin.   

Abstract

In a case control study 31 asymptomatic patients with asthma and/or hay fever and 31 normal controls had their bleeding time measured using the Simplate II device and venostasis. Mean bleeding time in the atopic group (527 s) was significantly prolonged compared to the controls (393 s) (p less than 0.0005). Platelet aggregation to collagen and ADP (but not to PAF-acether) was significantly depressed in the atopics. Mean circulating platelet mass was significantly greater in atopics than in the controls (p = 0.006). Stepwise multiple regression analysis showed that within the control group bleeding time was best predicted by platelet mass (p = 0.007). No such relationship was found in the atopics. However stepwise multiple regression analysis showed that bleeding time in the atopics (but not in the controls) was best predicted by PAF-acether induced platelet aggregability (p less than 0.05). In neither group was bleeding time related to collagen induced platelet thromboxane B2 production. It is hypothesised that in respiratory atopy the depressed aggregatory function of platelets is not compensated for sufficiently by an increase in platelet mass, leading to prolongation of the bleeding time. This haemostatic imbalance, whose cause remains to be established, appears to constitute a trait of atopy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3563961

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome.

Authors:  Alicja Kasperska-Zajac; Marek Nowakowski; Barbara Rogala
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

2.  The effect of cetirizine on antigen-dependent leucopenia in the guinea-pig.

Authors:  A J Coyle; J Lefort; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

3.  Circulating levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (suPAR) in patients with atopic eczema/dermatitis syndrome.

Authors:  Alicja Kasperska-Zajac; Barbara Rogala
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

4.  Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease.

Authors:  Chun-Na Jin; Hong Ma; Yan Lin; Jian-An Wang; Mei-Xiang Xiang
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

Review 5.  An Insight into Recent Advances on Platelet Function in Health and Disease.

Authors:  Preeti Kumari Chaudhary; Sanggu Kim; Soochong Kim
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

Review 6.  Platelet activation during allergic inflammation.

Authors:  Alicja Kasperska-Zajac; Barbara Rogala
Journal:  Inflammation       Date:  2007-10       Impact factor: 4.092

7.  PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle.

Authors:  A J Coyle; D Spina; C P Page
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

8.  The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.

Authors:  M L Taylor; G A Stewart; P J Thompson
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

9.  The synergistic effects of clopidogrel with montelukast may be beneficial for asthma treatment.

Authors:  Hoang Kim Tu Trinh; Thuy Van Thao Nguyen; Youngwoo Choi; Hae-Sim Park; Yoo Seob Shin
Journal:  J Cell Mol Med       Date:  2019-03-23       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.